In recent years, the potential of microbiome-based leads for the treatment of a myriad disease indications has been widely recognized, presenting lucrative ...
R A
Given the present scenario, many stakeholders are adopting such advanced marketing strategies to drive better consumer engagement through the use of immersive ...
The recent approval of Aduhelm™, an amyloid beta-directed antibody has led to players seeking approval for similar therapies; various interventions are being ...
Since the approval of Enbrel® in 1998 for the treatment of rheumatoid arthritis, Fc fusion therapies have evolved into a prominent class of therapeutics; ...
Owing to its several benefits, next generation sequencing (NGS) kits have emerged as a viable option for various drug developers to overcome the challenges ...
Driven by the growing complexity of modern pharmacological interventions, industry stakeholders have developed container-closures systems using more versatile ...
Roots Analysis has announced the addition of “Clinical Trials Software Market, 2022-2035” report to its list of offerings. Given the limitations ...
Owning to a variety of relevant reasons, which include trypanophobia and dependence on the cold chain, there is an evident demand for innovative and ...
Lately, drug manufacturers have started showing evident interest in modular facilities and using modularity in design approaches owing to the amplified value ...
The growing pipeline of biologics that can be produced in microbial systems, such as antibody fragments and plasmid-based therapies, is anticipated to offer ...
- 1
- 2
- 3
- …
- 39
- Next Page »